Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients

IntroductionCOVID-19 patients can develop autoantibodies against a variety of secreted and membrane proteins, including some expressed on lymphocytes. However, it is unclear what proportion of patients might develop anti-lymphocyte antibodies (ALAb) and what functional relevance they might have.Meth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Frontiers in Immunology
Main Authors: Ainhoa Pérez-Díez, Xiangdong Liu, Stephanie Calderon, Ashlynn Bennett, Andrea Lisco, Anela Kellog, Frances Galindo, Matthew J. Memoli, Joseph M. Rocco, Brian P. Epling, Elizabeth Laidlaw, Mike C. Sneller, Maura Manion, Glenn W. Wortmann, Rita Poon, Princy Kumar, Irini Sereti
Formato: Artigo
Publicado em: Frontiers Media S.A. 2024-04-01
Assuntos:
COVID-19
Autoantibodies
Complement deposition
Anti-lymphocyte Ab
Lymphopenia
Convalescent COVID-19
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1352330/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1352330/full

Registos relacionados